MedTrace Logo

Epilepsy Self-Management for Spanish Speakers: HOBSCOTCH - ESPANOL

NCT06462911 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-08-30

No results posted yet for this study

Summary

The goal of this pilot study is to assess the feasibility of translating and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with epilepsy whose primary language is Spanish.

The main questions it aims to answer are:

1. Can the current HOBSCOTCH program be successfully translated for Spanish speaking people with epilepsy?
2. Will people with epilepsy who speak Spanish experience improved quality of life similar to that found in people with epilepsy who received the HOBSCOTCH program in English?

Participants will be asked to:

* attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-SPANISH sessions with a one-on-one certified bilingual HOBSCOTCH coach
* complete a brief clinical questionnaire about their diagnosis of epilepsy
* complete two questionnaires before and after the HOBSCOTCH sessions about their quality of life and about memory and thinking processes
* keep a short daily diary about their seizures, symptoms and use of the self-management strategies taught in the HOBSCOTCH program
* complete a brief Satisfaction Survey and a 3 question survey about shared decision making after the entire HOBSCOTCH program

Conditions

  • Epilepsy
  • Cognitive Dysfunction
  • Memory Disorders

Interventions

BEHAVIORAL

HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH) - Spanish/Espanol

HOBSCOTCH is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barriers of access to care. The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life. The entire HOBSCOTCH program has been translated into Spanish for people with epilepsy who speak Spanish.

Sponsors & Collaborators

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Elaine T Kiriakopoulos, MD, MPH, MSc · Dartmouth-Health/Dartmouth-Hitchcock, Dartmouth College

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-01-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06462911 on ClinicalTrials.gov